AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Performer

7970.5000 -212.50 (-2.60%)

NSE May 09, 2025 15:31 PM

57.25% Gain from 52W Low

Volume: 14,627

AstraZeneca Pharma India Ltd.

08 May 2025, 01:34PM

7970.50

-2.60%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

More from AstraZeneca Pharma India Ltd.

Recommended

Five Interesting Stocks Today - May 09, 2025

The Baseline | 09 May 2025, 04:56PM

Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore

Trendlyne Marketwatch | 09 May 2025, 03:56PM

Superstar investor portfolios take a hit from market volatility | Screener: Promoters reducing their stakes

The Baseline | 09 May 2025, 12:37AM